Skip to main content
Top
Published in: Pediatric Rheumatology 1/2012

Open Access 01-12-2012 | Research

Application of the Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA)

Authors: Sharath Kumar, Divya Shree Kunhiraman, Lalitha Rajam

Published in: Pediatric Rheumatology | Issue 1/2012

Login to get access

Abstract

Background

Many children with sJIA may have a delayed onset of arthritis and so fail to fulfil the ILAR criteria for sJIA. This study was undertaken to determine whether the Yamaguchi criteria (for adult onset Still’s disease) is useful in classification of children with systemic juvenile idiopathic arthritis (sJIA) particularly in “pre-arthritic”, pure systemic, phase of the illness. A secondary objective was to determine the time delay between disease onset and onset of arthritis in our sJIA cohort.

Methods

Retrospective chart review all patients with a diagnosis of systemic juvenile arthritis in our department from Jan 1, 2004 to Jan 1, 2010.

Results

Twenty boys and eleven girls formed the study cohort. Thirteen patients were diagnosed with “suspected” sJIA due to typical systemic features but an absence of arthritis. Overall, the Yamaguchi criteria was fulfilled in a higher number of patients in the study (n=23) as compared to the ILAR criteria (n=18). Among the 13 “suspected” sJIA patients, 12 fulfilled the Yamaguchi criteria. Overall, either ILAR criteria or Yamaguchi criteria was fulfilled in 30 patients (96.8% of patients). The degree of association between the two criteria was poor (Phi coefficient = -0.352, p=0.05). Eleven out of eighteen patients with arthritis gave a history of delay in onset of arthritis (range=15 days to more than a year; median=30 days). Thus a total of 24 patients (75%) had a delay in onset of arthritis at onset of disease.

Conclusion

Patients with sJIA can have a significant period during their course (particularly at onset) when they do not have arthritis. The Yamaguchi criteria may be useful in this subset of patients in the “pre-arthritic” phase of the disease. Future criteria should incorporate the strengths of both, the Yamaguchi and the ILAR criteria.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ramanan AV, Grom AA: Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?. Rheumatol (Oxford). 2005, 44: 1350-1353. 10.1093/rheumatology/keh710.CrossRef Ramanan AV, Grom AA: Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?. Rheumatol (Oxford). 2005, 44: 1350-1353. 10.1093/rheumatology/keh710.CrossRef
2.
go back to reference De Benedetti F, Schneider R: Systemic juvenile idiopathic arthritis. Textbook of Pediatric Rheumatology. Edited by: Cassidy JT, Petty RE, Laxer RM, Lindsley CB. 2011, Philadelphia: Elsevier, 236-248. 6CrossRef De Benedetti F, Schneider R: Systemic juvenile idiopathic arthritis. Textbook of Pediatric Rheumatology. Edited by: Cassidy JT, Petty RE, Laxer RM, Lindsley CB. 2011, Philadelphia: Elsevier, 236-248. 6CrossRef
3.
go back to reference Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004, 31: 390-392.PubMed Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004, 31: 390-392.PubMed
4.
go back to reference Vastert S, De Jager W, Noordman BJ, Holzinger D, Prakken B, Wulffraat N: Anakinra in the early phase of systemic onset JIA: before the onset of arthritis. Ann Rheum Dis. 2011, 70 (Suppl 3): 408- Vastert S, De Jager W, Noordman BJ, Holzinger D, Prakken B, Wulffraat N: Anakinra in the early phase of systemic onset JIA: before the onset of arthritis. Ann Rheum Dis. 2011, 70 (Suppl 3): 408-
5.
go back to reference Cabane J, Michon A, Ziza JM, Bourgeois P, Bletry O, Godeau P: Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years. Ann Rheum Dis. 1990, 49: 283-285. 10.1136/ard.49.5.283.PubMedCentralCrossRefPubMed Cabane J, Michon A, Ziza JM, Bourgeois P, Bletry O, Godeau P: Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years. Ann Rheum Dis. 1990, 49: 283-285. 10.1136/ard.49.5.283.PubMedCentralCrossRefPubMed
6.
go back to reference Lin SJ, Chao HC, Yan DC: Different articular outcomes of Still's disease in Chinese children and adults. Clin Rheumatol. 2000, 19: 127-130. 10.1007/s100670050030.CrossRefPubMed Lin SJ, Chao HC, Yan DC: Different articular outcomes of Still's disease in Chinese children and adults. Clin Rheumatol. 2000, 19: 127-130. 10.1007/s100670050030.CrossRefPubMed
7.
go back to reference Luthi F, Zufferey P, Hofer MF, So AK: Adolescent-onset Still's disease:characteristics and outcome in comparison with adult-onset Still's disease. Clin Exp Rheumatol. 2002, 20: 427-430.PubMed Luthi F, Zufferey P, Hofer MF, So AK: Adolescent-onset Still's disease:characteristics and outcome in comparison with adult-onset Still's disease. Clin Exp Rheumatol. 2002, 20: 427-430.PubMed
8.
go back to reference Tanaka S, Matsumoto Y, Ohnishi H, Maeda M, Nishioka K, Kashiwazaki S: Comparison of clinical features of childhood and adult onset Still's disease. Ryumachi. 1991, 31: 511-518.PubMed Tanaka S, Matsumoto Y, Ohnishi H, Maeda M, Nishioka K, Kashiwazaki S: Comparison of clinical features of childhood and adult onset Still's disease. Ryumachi. 1991, 31: 511-518.PubMed
9.
go back to reference Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM: Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease. Br J Rheumatol. 1995, 34: 429-434. 10.1093/rheumatology/34.5.429.CrossRefPubMed Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM: Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease. Br J Rheumatol. 1995, 34: 429-434. 10.1093/rheumatology/34.5.429.CrossRefPubMed
10.
go back to reference Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H: Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992, 19: 424-430.PubMed Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H: Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992, 19: 424-430.PubMed
11.
go back to reference Masson C, Le LX, Loiter F, Dubos JJ, Bossier MC, Perroux-Goumy L: Comparative study of 6 types of criteria in adult Still's disease. J Rheumatol. 1996, 23: 495-497.PubMed Masson C, Le LX, Loiter F, Dubos JJ, Bossier MC, Perroux-Goumy L: Comparative study of 6 types of criteria in adult Still's disease. J Rheumatol. 1996, 23: 495-497.PubMed
12.
go back to reference Pascual V, Allantaz F, Patel P, Palucka AK, Chaussabel D, Banchereau J: How the study of children with rheumatic diseases identified interferon-α and interleukin-1 as novel therapeutic targets. Immunol Rev. 2008, 223: 39-59. 10.1111/j.1600-065X.2008.00643.x.PubMedCentralCrossRefPubMed Pascual V, Allantaz F, Patel P, Palucka AK, Chaussabel D, Banchereau J: How the study of children with rheumatic diseases identified interferon-α and interleukin-1 as novel therapeutic targets. Immunol Rev. 2008, 223: 39-59. 10.1111/j.1600-065X.2008.00643.x.PubMedCentralCrossRefPubMed
13.
go back to reference De Benedetti F: Targeting interleukin-6 in pediatric rheumatic diseases. Curr Opin Rheumatol. 2009, 21: 533-537. 10.1097/BOR.0b013e32832f1445.CrossRefPubMed De Benedetti F: Targeting interleukin-6 in pediatric rheumatic diseases. Curr Opin Rheumatol. 2009, 21: 533-537. 10.1097/BOR.0b013e32832f1445.CrossRefPubMed
14.
go back to reference Frosch M, Vogl T, Seeliger S, Wulffraat N, Kuis W, Viemann D: Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2622-2626. 10.1002/art.11177.CrossRefPubMed Frosch M, Vogl T, Seeliger S, Wulffraat N, Kuis W, Viemann D: Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2622-2626. 10.1002/art.11177.CrossRefPubMed
15.
go back to reference Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D: The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1 beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009, 60: 883-889. 10.1002/art.24349.CrossRefPubMed Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D: The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1 beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009, 60: 883-889. 10.1002/art.24349.CrossRefPubMed
16.
go back to reference Holzinger D, Frosch M, Kastrup A, Prince FHM, Otten MH, Van Suijlekom-Smit LWA: The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic onset juvenile idiopathic arthritis. Ann Rheum Dis. 2012, 10.1136/annrheumdis-2011-200598. Holzinger D, Frosch M, Kastrup A, Prince FHM, Otten MH, Van Suijlekom-Smit LWA: The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic onset juvenile idiopathic arthritis. Ann Rheum Dis. 2012, 10.1136/annrheumdis-2011-200598.
17.
go back to reference De Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ: Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009, 60: 2782-2793. 10.1002/art.24750.CrossRefPubMed De Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ: Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009, 60: 2782-2793. 10.1002/art.24750.CrossRefPubMed
18.
go back to reference de Jager W, Hoppenreijs EPAH, Wulffraat NM, Wedderburn LR, Kuis W, Berent J: Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007, 66: 589-598. 10.1136/ard.2006.061853.PubMedCentralCrossRefPubMed de Jager W, Hoppenreijs EPAH, Wulffraat NM, Wedderburn LR, Kuis W, Berent J: Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007, 66: 589-598. 10.1136/ard.2006.061853.PubMedCentralCrossRefPubMed
19.
go back to reference Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K: Highly elevated serum levels of interleukin18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum. 2002, 46: 2539-2541. 10.1002/art.10389. author reply 2541-2CrossRefPubMed Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K: Highly elevated serum levels of interleukin18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum. 2002, 46: 2539-2541. 10.1002/art.10389. author reply 2541-2CrossRefPubMed
20.
go back to reference Donn RP, Shelley E, Ollier WE, Thomson W, For the British Paediatric Rheumatology Study Group: A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2001, 44: 1782-1785. 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#.CrossRefPubMed Donn RP, Shelley E, Ollier WE, Thomson W, For the British Paediatric Rheumatology Study Group: A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2001, 44: 1782-1785. 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#.CrossRefPubMed
21.
go back to reference Meazza C, Travaglino P, Pignatti P, Magni-Manzoni S, Ravelli A, Martini A: Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002, 46: 232-237. 10.1002/1529-0131(200201)46:1<232::AID-ART10059>3.0.CO;2-B.CrossRefPubMed Meazza C, Travaglino P, Pignatti P, Magni-Manzoni S, Ravelli A, Martini A: Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002, 46: 232-237. 10.1002/1529-0131(200201)46:1<232::AID-ART10059>3.0.CO;2-B.CrossRefPubMed
22.
go back to reference Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J: S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum. 2008, 58: 3924-3931. 10.1002/art.24137.PubMedCentralCrossRefPubMed Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J: S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum. 2008, 58: 3924-3931. 10.1002/art.24137.PubMedCentralCrossRefPubMed
23.
go back to reference Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT: The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007, 56: 965-971. 10.1002/art.22416.CrossRefPubMed Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT: The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007, 56: 965-971. 10.1002/art.22416.CrossRefPubMed
24.
go back to reference Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A: Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005, 7: R30-R37. 10.1186/ar1453.PubMedCentralCrossRefPubMed Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A: Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005, 7: R30-R37. 10.1186/ar1453.PubMedCentralCrossRefPubMed
25.
go back to reference Ling XB, Park JL, Carroll T, Nguyen KD, Lau K, Macaubas C: Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics. 2010, 10: 4415-4430. 10.1002/pmic.201000298.PubMedCentralCrossRefPubMed Ling XB, Park JL, Carroll T, Nguyen KD, Lau K, Macaubas C: Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics. 2010, 10: 4415-4430. 10.1002/pmic.201000298.PubMedCentralCrossRefPubMed
26.
go back to reference Pay S, Turkcapar N, Kalyoncu M, Simsek I, Beyan E, Ertenli I: A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol. 2006, 25: 639-644.CrossRefPubMed Pay S, Turkcapar N, Kalyoncu M, Simsek I, Beyan E, Ertenli I: A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol. 2006, 25: 639-644.CrossRefPubMed
27.
go back to reference Behrens EM, Beukelman T, Gallo L, Spangler J, Rosenkranz M, Arkachaisri T: Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008, 35: 343-348.PubMed Behrens EM, Beukelman T, Gallo L, Spangler J, Rosenkranz M, Arkachaisri T: Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008, 35: 343-348.PubMed
29.
go back to reference Dewitt EM, Kimura Y, Bleukelman T, Nigrovic P, Onel K, Prahalad S, Schneider R: Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2012, 1-36. 10.1002/acr.21625. Dewitt EM, Kimura Y, Bleukelman T, Nigrovic P, Onel K, Prahalad S, Schneider R: Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2012, 1-36. 10.1002/acr.21625.
30.
go back to reference Modesto C, Woo P, García-Consuegra J, Merino R, García-Granero M, Arnal C: Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol. 2001, 19: 211-217.PubMed Modesto C, Woo P, García-Consuegra J, Merino R, García-Granero M, Arnal C: Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol. 2001, 19: 211-217.PubMed
31.
go back to reference Singh S, Salaria M, Kumar L, Minz R, Datta U, Sehgal S: Clinicoimmunological profile of juvenile rheumatoid arthritis at Chandigarh. Indian Pediatr. 1999, 36: 449-454.PubMed Singh S, Salaria M, Kumar L, Minz R, Datta U, Sehgal S: Clinicoimmunological profile of juvenile rheumatoid arthritis at Chandigarh. Indian Pediatr. 1999, 36: 449-454.PubMed
32.
go back to reference Seth V, Kabra SK, Semwa OP, Jain Y: Clinicoimmunological profile in juvenile rheumatoid arthritis—an Indian experience. Indian J Pediatr. 1996, 63: 293-300. 10.1007/BF02751521.CrossRefPubMed Seth V, Kabra SK, Semwa OP, Jain Y: Clinicoimmunological profile in juvenile rheumatoid arthritis—an Indian experience. Indian J Pediatr. 1996, 63: 293-300. 10.1007/BF02751521.CrossRefPubMed
33.
go back to reference Fantini F: Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. J Rheumatol. 2001, 28: 456-459.PubMed Fantini F: Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. J Rheumatol. 2001, 28: 456-459.PubMed
34.
go back to reference Ogilvie EM, Fife MS, Thompson SD: The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum. 2003, 48: 3202-3206. 10.1002/art.11300.CrossRefPubMed Ogilvie EM, Fife MS, Thompson SD: The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum. 2003, 48: 3202-3206. 10.1002/art.11300.CrossRefPubMed
35.
go back to reference Gattorno M, Piccini A, Lasigliè D, Tassi S, Brisca G, Carta S: The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2008, 58: 1505-1515. 10.1002/art.23437.CrossRefPubMed Gattorno M, Piccini A, Lasigliè D, Tassi S, Brisca G, Carta S: The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2008, 58: 1505-1515. 10.1002/art.23437.CrossRefPubMed
Metadata
Title
Application of the Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA)
Authors
Sharath Kumar
Divya Shree Kunhiraman
Lalitha Rajam
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2012
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-10-40

Other articles of this Issue 1/2012

Pediatric Rheumatology 1/2012 Go to the issue